Chen Shaokui, Liu Yulan, Wang Xiuying, Wang Haibo, Li Shuang, Shi Haifeng, Zhu Huiling, Zhang Jing, Pi Dingan, Hu Chien-An Andy, Lin Xi, Odle Jack
1 Hubei Collaborative Innovation Center for Animal Nutrition and Feed Safety, Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan, People's Republic of China.
2 Department of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Innate Immun. 2016 Nov;22(8):577-587. doi: 10.1177/1753425916664124. Epub 2016 Sep 21.
Asparagine (Asn), an activator of ornithine decarboxylase (ODC), stimulates cell proliferation in intestinal epithelial cells. We hypothesized that Asn can mitigate LPS-induced injury of intestinal structure and barrier function by regulating inflammatory signaling pathways. We executed the following experiment using weanling pigs for each of the groups: (1) non-challenged control; (2) LPS-challenged control; (3) LPS + 0.5% Asn; (4) LPS + 1.0% Asn. After 21-d feeding, pigs received an i.p. injection of either saline or LPS. Four h after injection, the mid-jejunum and mid-ileum samples were collected. We found that Asn restored ODC expression that was decreased by LPS treatment. Asn also restored intestinal morphology and barrier function that were impaired by LPS treatment. In addition, Asn down-regulated intestinal caspase-3 protein expression and TNF-α concentration, and decreased the mRNA expression of intestinal TLR4, TLR4 downstream signals (myeloid differentiation factor 88, IL-1 receptor-associated kinase 1 and TNF-α receptor-associated factor 6 and NOD1, NOD2 and their adaptor molecule (receptor-interacting serine/threonine-protein kinase 2). Moreover, Asn decreased p38 phosphorylation but increased ERK1/2 phosphorylation. Our results suggest that Asn improves intestinal integrity during an inflammatory insult, which appears to be related to the decrease of intestinal pro-inflammatory cytokine (via TLR4, NODs and p38) and of enterocyte apoptosis (via p38 and ERK1/2).
天冬酰胺(Asn)作为鸟氨酸脱羧酶(ODC)的激活剂,可刺激肠道上皮细胞的增殖。我们假设Asn可通过调节炎症信号通路减轻脂多糖(LPS)诱导的肠道结构和屏障功能损伤。我们对每组断奶仔猪进行了以下实验:(1)未受挑战的对照组;(2)LPS挑战对照组;(3)LPS + 0.5% Asn组;(4)LPS + 1.0% Asn组。饲养21天后,给仔猪腹腔注射生理盐水或LPS。注射后4小时,采集空肠中段和回肠中段样本。我们发现Asn可恢复LPS处理后降低的ODC表达。Asn还可恢复LPS处理受损的肠道形态和屏障功能。此外,Asn下调肠道半胱天冬酶-3蛋白表达和肿瘤坏死因子-α(TNF-α)浓度,并降低肠道Toll样受体4(TLR4)、TLR4下游信号(髓样分化因子88、白细胞介素-1受体相关激酶1和TNF-α受体相关因子6)以及核苷酸结合寡聚化结构域蛋白1(NOD1)、NOD2及其衔接分子(受体相互作用丝氨酸/苏氨酸蛋白激酶2)的mRNA表达。此外,Asn降低p38磷酸化水平,但增加细胞外信号调节激酶1/2(ERK1/2)磷酸化水平。我们的结果表明,Asn可改善炎症损伤期间的肠道完整性,这似乎与肠道促炎细胞因子(通过TLR4, NOD样受体和p38)和肠上皮细胞凋亡(通过p38和ERK1/2)的减少有关。